Novo Nordisk A/S (LON:0QIU)

Novo Nordisk Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	32,084	15,655	14,392	12,653	10,720	12,757
Short-Term Investments	499	10,653	15,838	10,921	6,765	-
Cash & Short-Term Investments	32,583	26,308	30,230	23,574	17,485	12,757
Cash Growth	-56.49%	-12.97%	28.23%	34.82%	37.06%	-17.56%
Accounts Receivable	75,421	71,949	64,770	50,560	40,643	27,734
Other Receivables	16,952	15,465	10,491	6,945	6,156	4,450
Receivables	92,373	87,414	75,261	57,505	46,799	32,184
Inventory	47,504	40,849	31,811	24,388	19,621	18,536
Other Current Assets	9,423	6,326	2,344	2,727	1,690	2,332
Total Current Assets	181,883	160,897	139,646	108,194	85,595	65,809
Property, Plant & Equipment	193,244	162,488	90,961	66,671	55,362	50,269
Long-Term Investments	2,725	2,677	1,663	1,343	1,441	1,648
Goodwill	-	20,064	4,464	4,615	4,346	-
Other Intangible Assets	106,587	91,026	55,942	46,324	38,825	20,657
Long-Term Deferred Tax Assets	22,772	24,627	20,380	13,904	8,672	5,865
Other Long-Term Assets	5,077	4,016	1,430	206	267	674
Total Assets	512,288	465,795	314,486	241,257	194,508	144,922
Accounts Payable	23,904	28,846	25,606	15,587	8,870	5,717
Accrued Expenses	-	118,928	600	875	-	-
Short-Term Debt	-	5,792	456	480	12,862	6,684
Current Portion of Long-Term Debt	12,034	5,983	4,848	-	-	-
Current Portion of Leases	-	1,338	1,174	986	822	775
Current Income Taxes Payable	22,335	9,716	7,116	7,091	3,658	3,913
Other Current Liabilities	176,085	46,925	129,855	95,921	73,304	53,184
Total Current Liabilities	234,358	217,528	169,655	120,940	99,516	70,273
Long-Term Debt	89,180	84,246	15,976	20,775	9,654	-
Long-Term Leases	-	5,428	4,552	3,543	3,307	2,897
Pension & Post-Retirement Benefits	751	903	742	762	1,280	1,399
Long-Term Deferred Tax Liabilities	9,268	5,426	10,162	7,061	5,271	2,502
Other Long-Term Liabilities	8,835	8,778	6,838	4,690	4,734	4,526
Total Liabilities	342,392	322,309	207,925	157,771	123,762	81,597
Common Stock	446	446	451	456	462	470
Retained Earnings	168,529	144,448	104,839	80,587	72,004	63,774
Treasury Stock	-2	-2	-5	-6	-6	-8
Comprehensive Income & Other	923	-1,406	1,276	2,449	-1,714	-911
Shareholders' Equity	169,896	143,486	106,561	83,486	70,746	63,325
Total Liabilities & Equity	512,288	465,795	314,486	241,257	194,508	144,922
Total Debt	101,214	102,787	27,006	25,784	26,645	10,356
Net Cash (Debt)	-68,631	-76,479	3,224	-2,210	-9,160	2,401
Net Cash Growth	-	-	-	-	-	-78.16%
Net Cash Per Share	-15.43	-17.14	0.72	-0.49	-1.99	0.51
Filing Date Shares Outstanding	4,443	4,441	4,458	4,501	4,558	4,625
Total Common Shares Outstanding	4,443	4,441	4,458	4,501	4,558	4,625
Working Capital	-52,475	-56,631	-30,009	-12,746	-13,921	-4,464
Book Value Per Share	38.23	32.31	23.90	18.55	15.52	13.69
Tangible Book Value	63,309	32,396	46,155	32,547	27,575	42,668
Tangible Book Value Per Share	14.25	7.29	10.35	7.23	6.05	9.23
Land	-	62,141	48,990	43,403	41,076	37,509
Machinery	-	73,365	49,930	45,662	43,720	38,379
Construction In Progress	-	79,378	39,663	22,361	11,091	10,798

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.